You are here: Industry Insights > Azithromycin

News List

Azithromycin API Bulk Price and Manufacturers in China PharmaSources
June 04, 2021
Azithromycin is an antibiotic that is used for treating bacterial infections commonly. The antibiotic belongs to the macrolides class of antibiotics.
Study finds rise in antibiotic misuse in India during COVID first wave expresspharma
July 06, 2021
The researchers estimated that COVID-19 likely contributed to 216.4 million excess doses of antibiotics and 38 million more doses of azithromycin in adults from June 2020 through September 2020.
India's COVID Crisis Could Spawn Another: Antibiotic Misuse drugs
July 06, 2021
While COVID-19 surged in India, so did the overuse or widespread misuse of antibiotics -- risking a future threat of drug-resistant bacteria.
Azithromycin and doxycycline of no benefit to COVID-19 patients, finds analysis europeanpharmaceuticalreview
February 03, 2021
Trial finds neither azithromycin nor doxycycline meaningfully improve recovery times or reduce risk of hospitalisation in non-hospitalised COVID-19 patients.
Phase IIb trial to study hydroxychloroquine and azithromycin as COVID-19 treatment launched europeanpharmaceuticalreview
May 19, 2020
A double-blind clinical trial has begun in the US to study hydroxychloroquine and azithromycin treatment in patients with COVID-19.
NIH panel warns against use of hydroxychloroquine to treat Covid-19 pharmaceutical-technology
April 23, 2020
A US National Institutes of Health (NIH) panel has recommended against the use of hydroxychloroquine in combination with azithromycin as a Covid-19 treatment.
Pfizer Advances Battle Against COVID-19 on Multiple Fronts contractpharma
April 14, 2020
Pfizer has released an update on important advances in the battle against the global COVID-19 pandemic.
Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19 worldpharmanews
April 09, 2020
Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware ...
FDA Warns About Increased Risk of Cancer Relapse with Long-Term Use of Azithromycin americanpharmaceuticalreview
August 07, 2018
The U.S. Food and Drug Administration (FDA) is warning that the antibiotic azithromycin (Zithromax, Zmax) should not be given long-term to prevent a certain inflammatory lung condition in patients with cancers of the blood or lymph nodes who undergo a don